Mataraza; Jennifer Marie
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mataraza; Jennifer Marie.The latest application filed is for "method of detecting tim-3 using antibody molecules to tim-3".
Company Profile
12.17.31
- Mataraza; Jennifer Marie - Cambridge MA
- Mataraza; Jennifer Marie - Brookline MA
- Mataraza; Jennifer Marie - Boston MA
Patent Activity
| Patent | Date |
|---|---|
| Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy Grant 11,413,340 - Brogdon , et al. August 16, 2 | 2022-08-16 |
| Method Of Detecting Tim-3 Using Antibody Molecules To Tim-3 App 20220185883 - Sabatos-Peyton; Catherine Anne ; et al. | 2022-06-16 |
| Combination Therapies Comprising Antibody Molecules To Lag-3 App 20220153835 - DRANOFF; Glenn ; et al. | 2022-05-19 |
| Combination Therapies Comprising Antibody Molecules To Tim-3 App 20220133889 - Dranoff; Glenn ; et al. | 2022-05-05 |
| Method of detecting TIM-3 using antibody molecules to TIM-3 Grant 11,155,620 - Sabatos-Peyton , et al. October 26, 2 | 2021-10-26 |
| Antibody Molecules To Pd-l1 And Uses Thereof App 20210284737 - Freeman; Gordon James ; et al. | 2021-09-16 |
| Antibody molecules to TIM-3 and uses thereof Grant 10,981,990 - Sabatos-Peyton , et al. April 20, 2 | 2021-04-20 |
| Antibody Molecules To Lag-3 And Uses Thereof App 20210009687 - Triebel; Frederic ; et al. | 2021-01-14 |
| Antibody molecules to PD-L1 and methods of treating cancer Grant 10,851,165 - Freeman , et al. December 1, 2 | 2020-12-01 |
| Antibody Molecules To Pd-1 And Uses Thereof App 20200339689 - Freeman; Gordon James ; et al. | 2020-10-29 |
| Antibody Molecules To Tim-3 And Uses Thereof App 20200308277 - Sabatos-Peyton; Catherine Anne ; et al. | 2020-10-01 |
| Combination Therapies App 20200277378 - Sabatos-Peyton; Catherine Anne ; et al. | 2020-09-03 |
| Antibody molecules to PD-1 and uses thereof Grant 10,752,687 - Freeman , et al. A | 2020-08-25 |
| Antibody Molecules To Tim-3 And Uses Thereof App 20200223917 - Sabatos-Peyton; Catherine Anne ; et al. | 2020-07-16 |
| Antibody molecules to LAG-3 and uses thereof Grant 10,711,060 - Triebel , et al. | 2020-07-14 |
| Antibody molecules to TIM-3 and uses thereof Grant 10,472,419 - Sabatos-Peyton , et al. Nov | 2019-11-12 |
| Fully Human Antibodies To Btla App 20190119381 - MATARAZA; Jennifer Marie ; et al. | 2019-04-25 |
| Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 Inhibitor For Combined Use In Anticancer Therapy App 20190000944 - Brogdon; Jennifer ; et al. | 2019-01-03 |
| Fully human antibodies to BTLA Grant 10,155,813 - Mataraza , et al. Dec | 2018-12-18 |
| Combination Therapies Comprising Antibody Molecules To Lag-3 App 20180340025 - Dranoff; Glenn ; et al. | 2018-11-29 |
| Combination Therapies Comprising Antibody Molecules To Pd-1 App 20180222982 - Dranoff; Glenn ; et al. | 2018-08-09 |
| Combination Therapies Comprising Antibody Molecules To Tim-3 App 20180207273 - Dranoff; Glenn ; et al. | 2018-07-26 |
| Antibody Molecules To Pd-l1 And Uses Thereof App 20180186882 - Freeman; Gordon James ; et al. | 2018-07-05 |
| Antibody Molecules To Pd-1 And Uses Thereof App 20180155427 - Freeman; Gordon James ; et al. | 2018-06-07 |
| Antibody molecules to PD-L1 and uses thereof Grant 9,988,452 - Freeman , et al. June 5, 2 | 2018-06-05 |
| Antibody Molecules To Lag-3 And Uses Thereof App 20180086830 - Triebel; Frederic ; et al. | 2018-03-29 |
| Antibody molecules to LAG-3 and uses thereof Grant 9,908,936 - Triebel , et al. March 6, 2 | 2018-03-06 |
| Antibody molecules to TIM-3 and uses thereof Grant 9,884,913 - Sabatos-Peyton , et al. February 6, 2 | 2018-02-06 |
| Antibody molecules to PD-1 and uses thereof Grant 9,815,898 - Freeman , et al. November 14, 2 | 2017-11-14 |
| Antibody Molecules To Pd-1 And Uses Thereof App 20170247456 - Freeman; Gordon James ; et al. | 2017-08-31 |
| Antibody Molecules To Lag-3 And Uses Thereof App 20170210804 - Triebel; Frederic ; et al. | 2017-07-27 |
| Antibody Molecules To Tim-3 And Uses Thereof App 20170198041 - Sabatos-Peyton; Catherine Anne ; et al. | 2017-07-13 |
| Antibody Molecules To Tim-3 And Uses Thereof App 20170190777 - Sabatos-Peyton; Catherine Anne ; et al. | 2017-07-06 |
| Antibody molecules to PD-1 and uses thereof Grant 9,683,048 - Freeman , et al. June 20, 2 | 2017-06-20 |
| Antibody molecules to TIM-3 and uses thereof Grant 9,605,070 - Sabatos-Peyton , et al. March 28, 2 | 2017-03-28 |
| Fully Human Antibodies To Btla App 20160222114 - MATARAZA; Jennifer Marie ; et al. | 2016-08-04 |
| Fully human antibodies to BTLA Grant 9,346,882 - Mataraza , et al. May 24, 2 | 2016-05-24 |
| Antibody Molecules To Pd-l1 And Uses Thereof App 20160108123 - Freeman; Gordon James ; et al. | 2016-04-21 |
| Antibody Molecules To Lag-3 And Uses Thereof App 20150259420 - Triebel; Frederic ; et al. | 2015-09-17 |
| Antibody Molecules To Tim-3 And Uses Thereof App 20150218274 - Sabatos-Peyton; Catherine Anne ; et al. | 2015-08-06 |
| Antibody Molecules To Pd-1 And Uses Thereof App 20150210769 - Freeman; Gordon James ; et al. | 2015-07-30 |
| Fully Human Antibodies To Btla App 20140017255 - MATARAZA; Jennifer Marie ; et al. | 2014-01-16 |
| Fully human antibodies to BTLA Grant 8,563,694 - Mataraza , et al. October 22, 2 | 2013-10-22 |
| Fully Human Antibodies To Btla App 20120183565 - Mataraza; Jennifer Marie ; et al. | 2012-07-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 